In vitro activity of linezolid and eperezolid against anaerobic bacteria

Clinical Microbiology and Infection

Volumn 5, Issue 1, 1999, Pages 51-53

  Edlund, Charlotta ^a,b   Oh, Herin ^a   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; EPEREZOLID; LINEZOLID;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; FUSOBACTERIUM; NONHUMAN; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SHORT SURVEY;

EID: 0032959296     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00099.x     Document Type: Article

References (8)

1. Ford CW, Hamel JC, Stapert D, et al. Oxazolidinones: new antibacterial agents. Trends Microbiol 1996; 5: 196-200.
2. Jones RN, Johnson DM, Erwin ME. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob Agents Chemother 1996; 40: 720-6.
3. Zurenco GE, Yagi BH, Schaadt RD, et al. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother 1996; 40: 839-45.
4. Finegold S. Anaerobic infections in humans: an overview. Anaerobe 1995; 1: 3-9.
5. Hedberg M, Nord CE. Antimicrobial-resistant anaerobic bacteria in human infections. Med Microbiol Lett 1996; 5: 295-304.
6. Summanen P, Baron E, Citron D, Strong C, Wexler H, Finegold S. Wadsworth anaerobic bacteriology manual, 5th edn. Los Angeles, CA: Veterans Administration Wadsworth Medical Center, 1993.
7. Schaadt RD, Batts DH, Daley-Yates PT, Pawsey SD, Stalker DJ, Zurenko GE. Serum inhibitory titers and serum bactericidal titers tor human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. Diagn Microbiol Infect Dis 1997; 28: 201-4.
8. Ford CW, Hamel JC, Wilsom DM, et al. The in vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob Agents Chemother 1996; 40: 1508-13.